CN112611789A - Biosensor based on lanthanum-doped zirconium-based MOF (Metal organic framework) derivative composite material and preparation method thereof - Google Patents
Biosensor based on lanthanum-doped zirconium-based MOF (Metal organic framework) derivative composite material and preparation method thereof Download PDFInfo
- Publication number
- CN112611789A CN112611789A CN202011321474.8A CN202011321474A CN112611789A CN 112611789 A CN112611789 A CN 112611789A CN 202011321474 A CN202011321474 A CN 202011321474A CN 112611789 A CN112611789 A CN 112611789A
- Authority
- CN
- China
- Prior art keywords
- zro
- electrode
- biosensor
- lanthanum
- composite material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/308—Electrodes, e.g. test electrodes; Half-cells at least partially made of carbon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
- G01N27/3277—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a redox reaction, e.g. detection by cyclic voltammetry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention provides a biosensor based on a lanthanum-doped zirconium-based MOF (metal organic framework) derivative composite material and a preparation method thereof2O3@ZrO2a/IL layer, a glutaraldehyde layer, a neurofilament antibody layer, a bovine serum albumin layer and a neurofilament protein layer. The biosensor prepared by the method is based on the zirconium-based metal organic framework composite pyrolysis material. The biosensor prepared by the method has the characteristics of low detection limit, wide linear range and the like, and can be used for quickly detecting the neurofilament protein.
Description
Technical Field
The invention belongs to the field of electrochemistry, relates to a biosensor, and particularly relates to a biosensor based on a lanthanum-doped zirconium-based MOF (metal organic framework) derivative composite material and a preparation method thereof.
Background
Neurodegenerative diseases are caused by the loss of neurons or their myelin sheaths, which worsen over time and become dysfunctional. It can be divided into two symptoms of acute and chronic diseases, and the acute disease mainly includes Cerebral Ischemia (CI), Brain Injury (BI), epilepsy, etc.; chronic disorders mainly include Alzheimer's Disease (AD), Parkinson's Disease (PD), Huntington's Disease (HD), Amyotrophic Lateral Sclerosis (ALS), and the like. When neurodegenerative diseases occur in humans, the immune system carries out natural immune defenses against them, during which neurofilament proteins are released into the blood, so that immunoassays for neurofilament proteins in plasma can be used as indicators of axonal damage in neurological diseases, as markers for neurodegenerative diseases. The neurofilament NF-L is a useful marker for monitoring diseases such as amyotrophic lateral sclerosis, multiple sclerosis and Huntington's disease.
Zirconium-based MOF (Zr-MOF, UiO-66-NH)2) Due to good chemical stability, high porosity, larger specific surface area, stronger thermal stability and good pH tolerance, the composite material has broad application prospect and is favored by researchers. More importantly, Zr-MOF is due to the interaction between zirconium clusters and amino ligands in the framework, compared to other MOFs materials, due to the interaction with-NH2The interaction of the groups results in selective adsorption of compounds containing the particular group. Thanks to the above excellent properties of Zr-MOFs, it has been widely used for catalysis, molecular adsorption and separation, drug delivery, and as a porous carrier. Zr-MOF usually exists in powder form, and is not easy to separate from a sample in practical use, so that the Zr-MOF is mostly fixed on various support materials for further application.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a biosensor based on a lanthanum-doped zirconium-based MOF (metal organic framework) derivative composite material and a preparation method thereof, and solve the technical problems that the detection limit of the biosensor is not low enough and the linear range is not wide enough in the prior art.
In order to solve the technical problems, the invention adopts the following technical scheme:
a biosensor based on a lanthanum-doped zirconium-based MOF derivative composite material comprises a carbon paste electrode and a modification on the surface of the carbon paste electrodeThe ornament is sequentially La from inside to outside2O3@ZrO2a/IL layer, a glutaraldehyde layer, a neurofilament antibody layer, a bovine serum albumin layer and a neurofilament protein layer.
The invention also has the following technical characteristics:
specifically, the La2O3@ZrO2In the alloy, the mass percentage of the La element is 0.05-0.5%.
Preferably, said La2O3@ZrO2In the above formula, La is contained in an amount of 0.1% by mass.
The IL is ionic liquid [ BMIm]BF4。
Specifically, La2O3@ZrO2The preparation process comprises the following steps:
step 2.1, adding zirconium tetrachloride and 2-amino terephthalic acid into an acetic acid solution, adding a lanthanum nitrate solution, and putting the mixture into a 120 ℃ oven for reaction for 24 hours;
step 2.2, centrifugally separating the reaction product obtained in the step 2.1, washing for many times, and drying in vacuum;
step 2.3, putting the product obtained in the step 2.2 into a double-tube carbon determination furnace in N2Heating to 900 ℃ for 3h under the condition; when the temperature is cooled to room temperature, slight grinding is carried out to obtain powdered La2O3@ZrO2。
Preferably, in step 2.1, 0.163g of 2-amino terephthalic acid is added for every 0.21g of zirconium tetrachloride, and 40mL of acetic acid solution is added for every 0.21g of zirconium tetrachloride;
adding 2-20 mL of lanthanum nitrate solution into every 0.21g of zirconium tetrachloride;
the acetic acid solution is an N, N-dimethylformamide solution containing acetic acid, and the volume concentration of the acetic acid is 0.12 mL/mL;
the lanthanum nitrate solution is an N, N-dimethylformamide solution containing lanthanum nitrate, and the concentration of the lanthanum nitrate is 1 mg/mL.
Preferably, in step 2.2, methanol and N, N-dimethylformamide are used in a volume ratio of 1: 4, washing the mixture for multiple times; the temperature for vacuum drying was 80 ℃.
The invention also provides a preparation method of the biosensor based on the lanthanum-doped zirconium-based MOF derivative composite material, which comprises the following steps:
step one, La is added2O3@ZrO2Ultrasonically dispersing the powder in PBS (phosphate buffer solution) of ionic liquid to form mixture suspension, transferring, dripping on the surface of carbon paste electrode, and air drying at room temperature to obtain La2O3@ZrO2The carbon paste electrode modified by the/IL composite membrane is marked as La2O3@ZrO2/IL/CPE；
Step two, in La2O3@ZrO2Dripping glutaraldehyde on the carbon paste electrode modified by the/IL composite membrane, drying in the air, dripping 5 mu L of neurofilament protein antibody, placing in a refrigerator, and drying in the air to obtain a modified electrode which is marked as anti-NF-L/GA/La2O3@ZrO2/IL/CPE；
And step three, continuously dripping bovine serum albumin solution with the mass fraction on the surface of the modified electrode in the step two to cover the area which is not modified by the antibody on the electrode, placing the electrode in a refrigerator, airing the electrode, washing the electrode with deionized water to prepare the biosensor based on the lanthanum-doped zirconium-based MOF derivative composite material, and recording the biosensor as NF-L/BSA/anti-NF-L/GA/La2O3@ZrO2/IL/CPE。
Preferably, the method is carried out according to the following steps:
step one, 5.0mgLa is added2O3@ZrO2Ultrasonically dispersing the powder in 1ml of LPBS solution containing 10 mu L of ionic liquid to form mixture suspension, transferring 10 mu L of the mixture suspension to the surface of a carbon paste electrode, and airing at room temperature to obtain La2O3@ZrO2The carbon paste electrode modified by the/IL composite membrane is marked as La2O3@ZrO2/IL/CPE；
Step two, in La2O3@ZrO2Dripping 5 mu L of glutaraldehyde with the volume fraction of 2.5% on the carbon paste electrode modified by the IL composite membrane, drying in the air, dripping 5 mu L of neurofilament protein antibody with the concentration of 40 mu g/mL, placing in a refrigerator, and drying in the air at 4 ℃ to obtain a modified electrode, which is recorded asanti-NF-L/GA/La2O3@ZrO2/IL/CPE；
And step three, continuously dropwise coating 5 mu L of bovine serum albumin solution with the mass fraction of 1% on the surface of the modified electrode in the step two to cover the area which is not modified by the antibody on the electrode, placing the electrode in a refrigerator, airing the electrode at 4 ℃, washing the electrode with deionized water for 2-3 times to prepare the biosensor based on the lanthanum-doped zirconium-based MOF derivative composite material, and recording the biosensor as NF-L/BSA/anti-NF-L/GA/La2O3@ZrO2/IL/CPE。
Preferably, before the carbon paste electrode is used, the carbon paste electrode needs to be polished into a mirror surface on weighing paper, and then the mirror surface is placed in a phosphate buffer solution to be subjected to cyclic voltammetry scanning for 10 periods, so that the carbon paste electrode is subjected to electrochemical activation treatment.
Compared with the prior art, the invention has the following technical effects:
the biosensor prepared by the method is a biosensor based on a zirconium-based metal organic framework composite pyrolysis material. The biosensor prepared by the method has the characteristics of low detection limit, wide linear range and the like, and can be used for quickly detecting the neurofilament protein.
(II) La is synthesized by the method of the invention2O3@ZrO2The material is used for preparing the neurofilament protein biosensor, the substrate electrode of the material is a carbon paste electrode, and modifiers on the surface of the carbon paste electrode are sequentially La from inside to outside2O3@ZrO2IL, glutaraldehyde, neurofilament antibodies, bovine serum albumin, and neurofilament proteins. The peak current and the mass concentration of the neural thread protein of the sensor present two-stage linear relationship, and the two-stage linear relationship is 0.05-5 ng.mL-1And 5 to 200 ng.mL-1The linear regression equation is respectively Ip3.26c (ng/mL) -40.92 and Ip0.024c (ng/mL) -22.16, detection limit of 0.012 ng/mL-1With a lower detection limit and a wider linear range.
Drawings
FIG. 1(A) is La2O3@ZrO2XRD spectrum of the material.
FIG. 1(B) is La2O3@ZrO2XPS spectrum of C element in material.
FIG. 1(C) is La2O3@ZrO2XPS spectrum of Zr element in the material.
FIG. 1(D) is La2O3@ZrO2XPS spectrum of La element in the material.
FIG. 2 is La2O3@ZrO2The total elemental mapping (B) of region (A) shown in (A), and the individual mapping of (C) Zr and (D) La atoms.
FIG. 3 shows La with different compounding ratios2O3@ZrO2Scanning electron micrographs of the materials (A), (B), (C), (D) and (E) and the results (F) of the measurements obtained by using them as sensors.
FIG. 4(A) is a cyclic voltammogram at different stages of the modified electrode.
FIG. 4(B) is an AC impedance diagram (a.La) of the modified electrode at different stages2O3@ZrO2/IL/CPE,b. anti-NF-L/GA/La2O3@ZrO2/IL/CPE,c.NF-L/BSA/anti-NF-L/GA/La2O3@ZrO2/IL/ CPE)。
FIG. 4(C) shows anti-NF-L/GA/La2O3@ZrO2Cyclic voltammograms of/IL/CPE at different scan rates (inset shows the relationship of oxidation peak ip, a and reduction peak ip, c with scan rate).
FIG. 5 shows the optimization of the mass concentration (A), incubation temperature (B) and time (C) of the antibody, and pH (D) of the working solution in the detection process of the biosensor prepared according to the present invention.
FIG. 6 is a differential pulse voltammetry curve (A) after immersion of a biosensor prepared according to the present invention in a neurofilament protein solution of different concentrations; FIGS. 6(B) and (C) are graphs obtained by linear fitting the results of the experiment for the analysis of the relationship between the NF-L mass concentration and the oxidation peak current.
The present invention will be explained in further detail with reference to examples.
Detailed Description
CPE refers to carbon paste electrode; IL refers to ionic liquids; GA refers to glutaraldehyde; anti-NF-L refers to neurofilament protein antibody; BSA refers to bovine serum albumin; NF-L refers to neurofilament protein.
Ionic liquids [ BMIm]BF4I.e. 1-butyl-3-methylimidazolium tetrafluoroborate, is a greenhouse ionic liquid with the molecular formula C8H15N2BF4。
The instruments and materials used in this example:
CHI660B electrochemistry workstation (Shanghai Chenghua instruments Co., Ltd.), electronic analytical balance (Shenyang Longteng electronic weighing instrument Co., Ltd.), electric hot air drying oven (Beijing Kogyo Yongxing instruments Co., Ltd.), ultrasonic cleaner (Zhejiang Ningbo instruments Co., Ltd.), magnetic heating stirrer (Changzhou Guohua instruments Co., Ltd.), X-ray diffractometer (Germany Bruker), scanning electron microscope (American FEI Co., Ltd.), vacuum drying oven (Tianjin Teshite instruments Co., Ltd.), double tube fixed carbon furnace (Beijing Kogyo Yongxing instruments Co., Ltd.), zirconium chloride (Guangdong Guanghua technology Co., Ltd.), 2-amino terephthalic acid (Hangzhou Kogyo chemical reagent Co., Ltd.), lanthanum nitrate (Xian Chemicals Co., Ltd.), N-dimethylformamide (Guangdong Hua Shuanghua instruments Co., Ltd.), powder (national medicine chemical reagent Co., Ltd.), Liquid paraffin (tianjin chemical reagent limited), potassium chloride (tianan chemical reagent factory), potassium dihydrogen phosphate (tianan chemical reagent factory), dipotassium hydrogen phosphate (tianan chemical reagent factory), potassium ferricyanide (tianjin remote chemical reagent limited), potassium ferrocyanide (tianjin remote chemical reagent limited), hydrogen peroxide (tianan chemical reagent factory), neurofilament protein antibody (shanghai an research biotechnology limited liability company), neurofilament protein (shanghai an research biotechnology limited liability company), Bovine Serum Albumin (BSA) > 98% (beijing obozocent biotechnology limited liability company).
The working base solution for impedance test contains 5.0mM K3Fe(CN)6/K4Fe(CN)6+0.1M KCl in 0.01M PBS.
Other measurements were carried out using 0.01M K in PBS buffer2HPO4And KH2PO4The stock solution is prepared, and the pH value of the stock solution is 0.01H of M3PO4And NaOH solution. The water used is double distilled water.
The following embodiments of the present invention are provided, and it should be noted that the present invention is not limited to the following embodiments, and all equivalent changes based on the technical solutions of the present invention are within the protection scope of the present invention.
Example 1:
this example presents a biosensor based on a lanthanum-doped zirconium-based MOF-derived composite, which is essentially the same as example 2, except that La is the only difference2O3@ZrO2In the above formula, the content of La was 0.05% by mass.
The material La2O3@ZrO2Was prepared essentially as in example 2, except that in step 2.1, 2mL of lanthanum nitrate solution (La (NO) was added3)3，1mg/mL DMF)。
The preparation method of the biosensor based on the lanthanum-doped zirconium-based MOF derived composite material of this example was the same as that of example 2.
Example 2:
the embodiment provides a biosensor based on a lanthanum-doped zirconium-based MOF (metal organic framework) derivative composite material, which comprises a carbon paste electrode and modifiers on the surface of the carbon paste electrode, wherein the modifiers are La from inside to outside in sequence2O3@ZrO2a/IL layer, a glutaraldehyde layer, a neurofilament antibody layer, a bovine serum albumin layer and a neurofilament protein layer.
La2O3@ZrO2In the above formula, La is contained in an amount of 0.1% by mass.
IL is an ionic liquid [ BMIm]BF4。
The preparation process of the carbon paste electrode comprises the following steps: 3.4g of graphite and 0.6g of liquid paraffin were thoroughly mixed and stirred to form a uniform paste. Putting into PVP tube with diameter of 3mm, compacting, inserting copper wire with appropriate length as wire, and making into Carbon Paste Electrode (CPE)
Before the carbon paste electrode is used, the carbon paste electrode needs to be polished into a mirror surface on weighing paper, then the mirror surface is placed in a phosphate buffer solution, cyclic voltammetry scanning is carried out for 10 periods, and electrochemical activation treatment is carried out on the carbon paste electrode.
The material La2O3@ZrO2The preparation process comprises the following steps:
step 2.1, 0.21g of zirconium tetrachloride (ZrCl)4) And 0.163g of 2-amino-terephthalic acid (H)2BDC-NH2) To 40mL of N, N-dimethylformamide containing 4.8mL of acetic acid was added, and 4mL of lanthanum nitrate solution (La (NO)3)31mg/mL DMF), and placing the mixture into a 120 ℃ oven for reaction for 24 hours;
step 2.2, the product is centrifuged, washed several times with a mixture of methanol and N, N-dimethylformamide (v/v ═ 1: 4) and dried under vacuum at 80 ℃;
step 2.3, the product (La/UiO-66-NH) is reacted2) Placing in a double-tube carbon determination furnace in N2Heating to 900 deg.C for 3 h. When the temperature is cooled to room temperature, slight grinding is carried out to obtain powdered La2O3@ZrO2。
The biosensor based on the lanthanum-doped zirconium-based MOF-derived composite material of the present example was prepared according to the following steps:
step one, 5.0mgLa is added2O3@ZrO2Ultrasonically dispersing the powder in 1ml of LPBS solution containing 10 mu L of ionic liquid to form mixture suspension, transferring 10 mu L of the mixture suspension to the surface of a carbon paste electrode, and airing at room temperature to obtain La2O3@ZrO2La as carbon paste electrode modified by/IL composite membrane2O3@ZrO2/IL/CPE；
Step two, in La2O3@ZrO2Dripping 5 mu L of glutaraldehyde with the volume fraction of 2.5% on a carbon paste electrode modified by an IL composite membrane, drying the glutaraldehyde, dripping 5 mu L of neurofilament protein antibody with the concentration of 40 mu g/mL after drying the glutaraldehyde, placing the neurofilament protein antibody in a refrigerator, and drying the neurofilament protein antibody at 4 ℃ to obtain a modified electrode, which is marked as anti-NF-L/GA/La2O3@ZrO2/IL/CPE；
Step three, continuously dripping 5 mu L of bovine serum albumin with the mass fraction of 1 percent on the surface of the modified electrode in the step twoAnd (3) placing the solution to cover the area which is not modified by the antibody on the electrode in a refrigerator, airing at 4 ℃, washing with deionized water for 2-3 times to prepare the biosensor based on the lanthanum-doped zirconium-based MOF-derived composite material, and marking the biosensor as NF-L/BSA/anti-NF-L/GA/La2O3@ZrO2/IL/CPE。
Example 3:
this example presents a biosensor based on a lanthanum-doped zirconium-based MOF-derived composite, which is essentially the same as example 2, except that La is the only difference2O3@ZrO2In the above formula, the content of La was 0.25% by mass.
The material La2O3@ZrO2Was prepared essentially as in example 2, except that, in step 2.1, 10mL of lanthanum nitrate solution (La (NO) was added3)3，1mg/mL DMF)。
The preparation method of the biosensor based on the lanthanum-doped zirconium-based MOF derived composite material of this example was the same as that of example 2.
Example 4:
this example presents a method for the preparation of a biosensor based on a lanthanum-doped zirconium-based MOF-derived composite, which is substantially identical to that of example 2, except that La is the only difference2O3@ZrO2In the above formula, the content of La was 0.5% by mass.
The material La2O3@ZrO2Was prepared essentially as in example 2, except that in step 2.1, 20mL of lanthanum nitrate solution (La (NO) was added3)3，1mg/mL DMF)。
The preparation method of the biosensor based on the lanthanum-doped zirconium-based MOF derived composite material of this example was the same as that of example 2.
La2O3@ZrO2Characterization of the materials:
FIG. 1 is a graph showing the microstructure of the prepared La2O3@ZrO2The material was characterized.
FIG. 1(A) is La2O3@ZrO2The XRD pattern of (a) shows that the sample has a broad diffraction peak at about 24 °, which corresponds to the diffraction of the (002) crystal plane of graphitic carbon. It can also be seen that peaks appear in the vicinity of 30, 50 and 59, which correspond to ZrO respectively2The (111), (202) and (131) crystal planes of (a).
At the same time, for the prepared La2O3@ZrO2The material was XPS characterized to further elucidate the La synthesized2O3@ZrO2The state of the individual elements in the material. As a result, as shown in FIG. 1(B), the spectrum of C1 s can be decomposed into three peaks, which are located at 284.8eV, 286.1eV, and 288.9eV, respectively, and which correspond to the three states of C-C, C-O, or C-N and O-C ═ O of C. As can be seen from FIG. 1(C), the spectrum of Zr 3d has two peaks, the peak at 182.5eV belongs to Zr 3d5/2 and the peak at 185.0eV belongs to Zr 3d3/2, which indicate that Zr is Zr in the synthesized material4+The state of (2) exists. FIG. 1(D) shows two double peaks near 834.9eV and 853.8eV, which are peaks for La 3D5/2 and La 3D3/2, illustrating La as La after calcination2O3Doped in the material.
The elemental surface distribution of the material was analyzed by an energy spectrometer in an SEM electron microscope, and the results are shown in fig. 2. The red-box region in FIG. 2(A) was analyzed, wherein FIG. 2(B) is the total mapping map, and (C) and (D) are the mapping of Zr and La elements, respectively. As can be seen from the figure, both Zr and La are uniformly distributed in the material, but the spectrum brightness is lower compared to Zr because of the smaller La content.
Influence of addition of La element on the material:
in order to study the effect of the addition of La on the material, SEM images of materials with different La composite ratios are compared. As shown in fig. 3(a), the surface of the material exhibited a pillar-like, particle-close packed morphology prior to the un-recombination of La. From FIGS. 3(B) and 3(C), it can be seen that La (NO) is added3)3The surface of the material is more uniform and appears more loose, showing a dendritic structure. The composition of the La element improves the specific surface area of the material and simultaneously improves the porosity of the material. But at the beginningAfter increasing the compounding ratio, the material will agglomerate to some extent, but the specific surface area and porosity of the material will decrease (FIG. 3 (D, E)). Meanwhile, La with different composite ratios is compared2O3@ZrO2The sensor made of the material detects the same concentration of NF-L, as can be seen from FIG. 3(F), La with the La compounding ratio of 0.1 percent2O3@ZrO2With the best detection results. The appearance of the synthesized material is easy to adsorb under the composite proportion, which is beneficial to the loading of protein, increases the immobilized amount of enzyme on the surface of an electrode and improves the electrocatalytic efficiency of the material. Therefore, the composite proportion of 0.1 percent is selected as La2O3@ZrO2The optimal La composite ratio.
Electrochemical properties of electrodes in sensors at different modification stages:
the electrochemical properties of the electrodes in the sensor at different modification stages can be analyzed by CV. As shown in FIG. 4(A), curve a is La2O3@ZrO2CV curve of/IL/CPE, La can be seen2O3@ZrO2The curve of/IL/CPE has a pair of reversible redox peaks, the peak shape is obvious and the peak current is large, which indicates that La2O3@ZrO2The material has good electron transfer capability. And further modifying the surface of the electrode with a cross-linking agent for fixing anti-NF-L, wherein the redox peak shape is unchanged but the peak current is reduced (curve b), and because the antibody is a biological macromolecule, the conductivity is poor, and when the antibody is modified on the surface of the electrode, the conductivity of the electrode is reduced. Finally, after the modified electrode is specifically and immunologically combined with NF-L, the biosensor based on the lanthanum-doped zirconium-based MOF derivative composite material NF-L/BSA/anti-NF-L/GA/La2O3@ZrO2There is a significant decrease in peak current of the CV curve for/IL/CPE (curve c). This is because the antigen-antibody binding covers the electrode surface, and the addition of BSA also blocks the regions of the modified electrode surface not covered by antibody-specific binding.
In addition to CV, EIS can also analyze the surface electron transport at different stages of electrode modification. The results are shown in FIG. 4(B), and it is evident that half of the CPE impedance curveThe diameter is the largest, which indicates that the conductivity of the bare electrode is not good, and La is modified on the surface of the electrode2O3@ZrO2after/IL, La2O3@ZrO2The radius of the impedance curve of/IL/CPE becomes minimal, indicating that La2O3@ZrO2The material can effectively improve the electron transfer capability on the surface of the electrode. Then, anti-NF-L is fixed on the surface of the electrode through a cross-linking agent, and BSA/anti-NF-L/GA/La is formed after the incubation in NF-L2O3@ZrO2/IL/CPE with impedance values compared to La2O3@ZrO2the/IL/CPE is obviously increased because the substances such as antigen antibody, BSA, etc. have poor conductivity, and after the substances are combined with each other on the surface of the electrode in an interaction way, the transfer of electrons on the surface of the electrode is hindered. And analyzing the electrode surface states of all stages in the sensor construction process by combining the obtained results analyzed by the CV, which indicates that the NF-L immunosensor is successfully prepared and can be used for detecting NF-L.
The electrochemical behavior of the immunosensor can be further analyzed by CV curves at different sweeps. FIG. 4(C) shows NF-L/BSA/anti-NF-L/GA/La at different scanning speeds in the range of 0.05-0.5V/s2O3 @ZrO2The CV curve of/IL/CPE is shown in the figure, when the scanning speed is lower, the oxidation reduction peak type of the curve is obvious, and the symmetrical peak heights of the peak shapes are equal, which indicates that the reversibility of the electrode reaction is good; when the scanning rate is increased, the peak current of the oxidation-reduction peak is increased, and at the same time, the oxidation peak potential is shifted positively, the reduction peak potential is shifted negatively, and the potential difference is increased accordingly. The calculation result shows that the current magnitude and the scanning rate are in a linear relation, and the linear equations are respectively oxidation peaks: ip, a ═ 472.55V1/2(V · s-1) +16.95(R ═ 0.999), reduction peak: ip, c-602.76V 1/2(V · s-1) -64.95 (R-0.999), which indicates that the redox reaction process at the electrode surface is diffusion-controlled.
Selection of NF-L immunosensor experimental conditions:
FIG. 5 is a selection of NF-L immunosensor assay conditions. NF-L immunosensor is a neurofilament protein biosensor.
In the electrochemical experiment process, the experimental condition of the immune reaction has a great influence on the magnitude of the response signal. The following different experimental conditions were investigated for their effect on the current response of an electrochemical sensor. First, the influence of the amount of the antibody immobilized on the electrode surface on the detection result. As shown in FIG. 5(A), the sensor current response value gradually decreases when the antibody concentration gradually increases, and when the antibody mass concentration reaches 40. mu.g/mL, the sensor response current does not change much with the increase of the antibody concentration, which indicates that the fixed amount of the antibody on the electrode surface is saturated. Therefore, the antibody concentration of 40. mu.g/mL was used as the optimum experimental condition for detection. For the electrochemical immunosensor, not only the preparation condition of the sensor has an influence on the detection result, but also the detection condition has a certain influence on the result. Wherein the incubation conditions alter the current response of the sensor by affecting the binding of the antigen-antibody in an immune response. The temperature and time during the incubation process were optimized by first analyzing the effect of the incubation temperature on the assay results, testing the immunosensor obtained above for a 1ng/mL NF-L solution, setting the assay temperatures to 27, 32, 37, 42, and 47 ℃ in that order, and recording the response current of the sensor after 40min of incubation. As shown in fig. 5(B), the peak current value of the sensor becomes small when the temperature becomes high, but the peak current value of the sensor becomes large when the temperature is more than 37 ℃. This is because the binding of antigen-antibody is accelerated by increasing the temperature below 37 ℃, but the detection effect is reduced by inactivating the antigen-antibody to some extent when the temperature is above 37 ℃. Therefore 37 ℃ was chosen as the optimal incubation temperature. FIG. 5(C) is a graph showing the effect of incubation time on the results of detection, in which the immunosensor was immersed in NF-L solution at 1ng/mL and incubated at 37 ℃ for selected times, wherein the incubation time was set to 20, 30, 40, 50, and 60min, respectively. As the immune reaction proceeds, the antigen-antibody is combined on the surface of the electrode to block the electron transfer, so that the response current of the immunosensor is gradually reduced, and when the incubation time reaches 50min and the incubation is continued, the response current is not changed greatly, because the reaction of the antigen-antibody on the surface of the electrode reaches the dynamic equilibrium, and the reaction can not be promoted any more by the continued incubation. Therefore 50min was chosen as the optimal incubation time. Meanwhile, the pH value of the working base solution can influence the activities of the antigen and the antibody, and can also influence the stability and the affinity of the antigen-antibody compound on the surface of the electrode, thereby influencing the sensitivity of the immunosensor. The effect of different pH values on the assay results was studied by immersing the prepared immunosensor in 1ng/mL NF-L solution and incubating at 37 ℃ for 50min, with pH values selected at 5, 6, 7, 8, and 9, respectively. As a result, as shown in fig. 5(D), it can be seen that the value of the response peak current is the largest when the pH is 7, and the detection effect of the sensor is reduced when the pH is higher or lower than 7. Therefore, the working base solution with pH 7.0 was selected as the optimum experimental condition.
And (3) NF-L analysis and detection:
when the NF-L analysis and detection is carried out, the optimum experimental conditions discussed above are selected, and NF-L/BSA/anti-NF-L/GA/La is carried out at the temperature of 37 DEG C2O3@ZrO2the/IL/CPE was immersed in solutions to be tested at different NF-L concentrations at pH 7.0 and incubated for 50min before testing the immunosensor for DPV response. As a result, as shown in fig. 6(a), the antigen-antibody immunoreaction occurred on the electrode surface with the increase of the NF-L concentration, and a complex was formed, and the formed complex was accumulated on the electrode surface, thereby blocking the current response, and the peak current value thereof was gradually decreased. In order to analyze the relationship between the mass concentration of NF-L and the oxidation peak current, the obtained experimental results are subjected to linear fitting. Two methods are respectively selected for fitting, one method is direct linear analysis of NF-L mass concentration and oxidation peak current, and the result shows two-stage linear relation of 0.05-5 ng.mL-1And 5 to 200ng m L-1The linear regression equation is Ip ═ 3.26c (ng · mL) respectively-1) -40.92 (R ═ 0.986) and Ip ═ 0.024c (n g · mL)-1) -22.16 (R ═ 0.996), with a signal-to-noise ratio of 3 and a detection limit of 0.012ng · mL-1. The other is to analyze the indexes of NF-L mass concentration and oxidation peak current, and the result shows that the mass concentration of the NF-L is 0.1-100 ng. m L-1In the range of (1), the linear regression equation is Ip ═ 7.84log c (ng · mL)-1) -34.28 (R ═ 0.981), with a signal-to-noise ratio of 3 and a detection limit of 0.034ng · mL-1. Both of which indicate the immunosensor deviceHas a lower detection limit and a wider linear range.
Claims (10)
1. The biosensor based on the lanthanum-doped zirconium-based MOF derivative composite material comprises a carbon paste electrode and is characterized by further comprising a modifier on the surface of the carbon paste electrode, wherein the modifier is La sequentially from inside to outside2O3@ZrO2a/IL layer, a glutaraldehyde layer, a neurofilament antibody layer, a bovine serum albumin layer and a neurofilament protein layer.
2. The biosensor of claim 1, wherein the La doped zirconium based MOF derivative composite material2O3@ZrO2In the alloy, the mass percentage of the La element is 0.05-0.5%.
3. The biosensor of claim 2, wherein the La doped zirconium based MOF derivative composite material2O3@ZrO2In the above formula, La is contained in an amount of 0.1% by mass.
4. The biosensor of claim 1, wherein the IL is an ionic liquid [ BMIm ]]BF4。
5. The biosensor of claim 1, wherein the La doped zirconium based MOF derivative composite material2O3@ZrO2The preparation process comprises the following steps:
step 2.1, adding zirconium tetrachloride and 2-amino terephthalic acid into an acetic acid solution, adding a lanthanum nitrate solution, and putting the mixture into a 120 ℃ oven for reaction for 24 hours;
step 2.2, centrifugally separating the reaction product obtained in the step 2.1, washing for many times, and drying in vacuum;
step 2.3, putting the product obtained in the step 2.2 into a double-tube carbon determination furnace in N2Heating to 900 ℃ for 3h under the condition; when the temperature is cooled toSlightly grinding at room temperature to obtain powdered La2O3@ZrO2。
6. The biosensor based on a lanthanum doped zirconium based MOF derivative composite material according to claim 5, wherein in step 2.1, for every 0.21g of zirconium tetrachloride, 0.163g of 2-amino terephthalic acid is added, for 40mL of acetic acid solution;
adding 2-20 mL of lanthanum nitrate solution into every 0.21g of zirconium tetrachloride;
the acetic acid solution is an N, N-dimethylformamide solution containing acetic acid, and the volume concentration of the acetic acid is 0.12 mL/mL;
the lanthanum nitrate solution is an N, N-dimethylformamide solution containing lanthanum nitrate, and the concentration of the lanthanum nitrate is 1 mg/mL.
7. The biosensor based on a lanthanum-doped zirconium-based MOF derivative composite according to claim 5, wherein in step 2.2, methanol and N, N-dimethylformamide are used in a volume ratio of 1: 4, washing the mixture for multiple times; the temperature for vacuum drying was 80 ℃.
8. A biosensor based on a lanthanum doped zirconium based MOF derived composite material according to any of claims 1 to 7, wherein the method is performed according to the following steps:
step one, La is added2O3@ZrO2Ultrasonically dispersing the powder in PBS (phosphate buffer solution) of ionic liquid to form mixture suspension, transferring, dripping on the surface of carbon paste electrode, and air drying at room temperature to obtain La2O3@ZrO2The carbon paste electrode modified by the/IL composite membrane is marked as La2O3@ZrO2/IL/CPE；
Step two, in La2O3@ZrO2Dripping glutaraldehyde on the carbon paste electrode modified by the/IL composite membrane, drying in the air, dripping 5 mu L of neurofilament protein antibody, placing in a refrigerator, and drying in the air to obtain a modified electrode which is marked as anti-NF-L/GA/La2O3@ZrO2/IL/CPE；
And step three, continuously dripping bovine serum albumin solution with the mass fraction on the surface of the modified electrode in the step two to cover the area which is not modified by the antibody on the electrode, placing the electrode in a refrigerator, airing the electrode, washing the electrode with deionized water to prepare the biosensor based on the lanthanum-doped zirconium-based MOF derivative composite material, and recording the biosensor as NF-L/BSA/anti-NF-L/GA/La2O3@ZrO2/IL/CPE。
9. The method of making a lanthanum doped zirconium based MOF derivative composite based biosensor according to claim 8, wherein the method is performed according to the following steps:
step one, 5.0mgLa is added2O3@ZrO2Ultrasonically dispersing the powder in 1ml of LPBS solution containing 10 mu L of ionic liquid to form mixture suspension, transferring 10 mu L of the mixture suspension to the surface of a carbon paste electrode, and airing at room temperature to obtain La2O3@ZrO2The carbon paste electrode modified by the/IL composite membrane is marked as La2O3@ZrO2/IL/CPE；
Step two, in La2O3@ZrO2Dripping 5 mu L of glutaraldehyde with the volume fraction of 2.5% on a carbon paste electrode modified by an IL composite membrane, drying the glutaraldehyde, dripping 5 mu L of neurofilament protein antibody with the concentration of 40 mu g/mL after drying the glutaraldehyde, placing the neurofilament protein antibody in a refrigerator, and drying the neurofilament protein antibody at 4 ℃ to obtain a modified electrode, which is marked as anti-NF-L/GA/La2O3@ZrO2/IL/CPE；
And step three, continuously dropwise coating 5 mu L of bovine serum albumin solution with the mass fraction of 1% on the surface of the modified electrode in the step two to cover the area which is not modified by the antibody on the electrode, placing the electrode in a refrigerator, airing the electrode at 4 ℃, washing the electrode with deionized water for 2-3 times to prepare the biosensor based on the lanthanum-doped zirconium-based MOF derivative composite material, and recording the biosensor as NF-L/BSA/anti-NF-L/GA/La2O3@ZrO2/IL/CPE。
10. The method of claim 8, wherein the carbon paste electrode is polished to a mirror surface on a weighing paper before use, and then placed in a phosphate buffer solution for cyclic voltammetric scanning for 10 periods to perform electrochemical activation treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011321474.8A CN112611789B (en) | 2020-11-23 | 2020-11-23 | Biosensor based on lanthanum-doped zirconium-based MOF (Metal organic framework) derived composite material and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011321474.8A CN112611789B (en) | 2020-11-23 | 2020-11-23 | Biosensor based on lanthanum-doped zirconium-based MOF (Metal organic framework) derived composite material and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112611789A true CN112611789A (en) | 2021-04-06 |
| CN112611789B CN112611789B (en) | 2023-03-24 |
Family
ID=75224973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011321474.8A Active CN112611789B (en) | 2020-11-23 | 2020-11-23 | Biosensor based on lanthanum-doped zirconium-based MOF (Metal organic framework) derived composite material and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112611789B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114813862A (en) * | 2021-11-12 | 2022-07-29 | 重庆大学 | Electrochemical biosensor and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090110041A (en) * | 2008-04-17 | 2009-10-21 | 한국화학연구원 | Ultraporous organic-inorganic nanoporous composites formed by covalent bonding between inorganic-organic hybrids and mesocellular mesoporous materials |
| WO2010038205A1 (en) * | 2008-09-30 | 2010-04-08 | Saint-Gobain Centre De Recherches Et D'etudes Europeen | Method for manufacturing a zirconium derivative, hydrate, or oxide |
| CN103267788A (en) * | 2013-04-23 | 2013-08-28 | 西安建筑科技大学 | Preparation method of metal-doped carbon aerogel/myoglobin/ionic liquid modified carbon paste electrode |
| US20140330020A1 (en) * | 2011-10-03 | 2014-11-06 | Council Of Scientific And Industrial Research | Water soluble metal-organic frameworks (mofs) |
| CN105572193A (en) * | 2016-02-25 | 2016-05-11 | 王亚莉 | Preparation method and application of electrochemical chlordimeform sensor based on composite cerium-doped porous nanocomposite |
| CN106268707A (en) * | 2016-08-11 | 2017-01-04 | 北京蛋白质组研究中心 | A kind of phosphoeptide based on novel magnetic porous material enrichment new method |
| CN107029805A (en) * | 2017-05-02 | 2017-08-11 | 南京工程学院 | Carried noble metal nano-cluster catalytic composite materials and preparation method thereof |
-
2020
- 2020-11-23 CN CN202011321474.8A patent/CN112611789B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090110041A (en) * | 2008-04-17 | 2009-10-21 | 한국화학연구원 | Ultraporous organic-inorganic nanoporous composites formed by covalent bonding between inorganic-organic hybrids and mesocellular mesoporous materials |
| WO2010038205A1 (en) * | 2008-09-30 | 2010-04-08 | Saint-Gobain Centre De Recherches Et D'etudes Europeen | Method for manufacturing a zirconium derivative, hydrate, or oxide |
| US20140330020A1 (en) * | 2011-10-03 | 2014-11-06 | Council Of Scientific And Industrial Research | Water soluble metal-organic frameworks (mofs) |
| CN103267788A (en) * | 2013-04-23 | 2013-08-28 | 西安建筑科技大学 | Preparation method of metal-doped carbon aerogel/myoglobin/ionic liquid modified carbon paste electrode |
| CN105572193A (en) * | 2016-02-25 | 2016-05-11 | 王亚莉 | Preparation method and application of electrochemical chlordimeform sensor based on composite cerium-doped porous nanocomposite |
| CN106268707A (en) * | 2016-08-11 | 2017-01-04 | 北京蛋白质组研究中心 | A kind of phosphoeptide based on novel magnetic porous material enrichment new method |
| CN107029805A (en) * | 2017-05-02 | 2017-08-11 | 南京工程学院 | Carried noble metal nano-cluster catalytic composite materials and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 郭家林等: "金属有机骨架光催化材料研究进展", 《河南科技学院学报(自然科学版)》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114813862A (en) * | 2021-11-12 | 2022-07-29 | 重庆大学 | Electrochemical biosensor and application thereof |
| CN114813862B (en) * | 2021-11-12 | 2024-03-26 | 重庆大学 | Electrochemical biosensor and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112611789B (en) | 2023-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Preparation of graphene nano-sheet bonded PDA/MOF microcapsules with immobilized glucose oxidase as a mimetic multi-enzyme system for electrochemical sensing of glucose | |
| Gao et al. | Polyamidoamine dendrimers-capped carbon dots/Au nanocrystal nanocomposites and its application for electrochemical immunosensor | |
| Xu et al. | Triple tumor markers assay based on carbon–gold nanocomposite | |
| Wang et al. | Magnetic Fe 3 O 4@ MOFs decorated graphene nanocomposites as novel electrochemical sensor for ultrasensitive detection of dopamine | |
| Gao et al. | One step electrochemically deposited nanocomposite film of chitosan–carbon nanotubes–gold nanoparticles for carcinoembryonic antigen immunosensor application | |
| Feng et al. | Nanoporous PtCo-based ultrasensitive enzyme-free immunosensor for zeranoldetection | |
| CN108311125B (en) | Solid phase micro-extraction coating based on hollow carbon nano material and preparation method thereof | |
| CN110006977B (en) | CuFe2O4Preparation of nano microsphere electrochemical sensor and method for detecting lysozyme | |
| Zhang et al. | A novel immunosensor based on an alternate strategy of electrodeposition and self-assembly | |
| Wang et al. | Ultrasensitive electrochemical sensing of dopamine using reduced graphene oxide sheets decorated with p-toluenesulfonate-doped polypyrrole/Fe 3 O 4 nanospheres | |
| Guo et al. | A label-free electrochemical aptasensor based on electrodeposited gold nanoparticles and methylene blue for tetracycline detection | |
| Zhou et al. | A nanocomposite consisting of ionic liquid-functionalized layered Mg (II)/Al (III) double hydroxides for simultaneous electrochemical determination of cadmium (II), copper (II), mercury (II) and lead (II) | |
| Wang et al. | Graphene-Prussian blue/gold nanoparticles based electrochemical immunoassay of carcinoembryonic antigen | |
| CN112611789B (en) | Biosensor based on lanthanum-doped zirconium-based MOF (Metal organic framework) derived composite material and preparation method thereof | |
| Qu et al. | A signal-off electrochemical sensing platform based on Fe3S4-Pd and pineal mesoporous bioactive glass for procalcitonin detection | |
| Zhu et al. | Rapid fabrication of electrode for the detection of alpha fetoprotein based on MnO2 functionalized mesoporous carbon hollow sphere | |
| Li et al. | A neurofilament-light chains electrochemical immunosensor expected to reveal the early stage of neurodegenerative diseases | |
| Zhang et al. | An ultrasensitive dual-signal ratio electrochemical aptamer biosensor for the detection of HER2 | |
| Yang et al. | Novel dual-recognition electrochemical biosensor for the sensitive detection of AFM1 in milk | |
| Wang et al. | An enhanced oxime-based biomimetic electrochemical sensor modified with multifunctional AuNPs–Co 3 O 4–NG composites for dimethoate determination | |
| CN110702759B (en) | ZIF-8 composite material electrochemical immunosensor for detecting alpha fetoprotein and preparation method and application thereof | |
| CN110261450B (en) | Glassy carbon electrode capable of simultaneously detecting dopamine and epinephrine modification, and preparation method and application thereof | |
| Ye et al. | Ag nanoparticles/PbTiO3 with in-situ photocatalytic process and its application in an ultra-sensitive molecularly imprinted hemoglobin detection | |
| Ma et al. | The preparation of C-reactive protein immunosensor based on nano-mimetic enzyme Co3O4 | |
| Herrasti et al. | Improved magnetosensor for the detection of hydrogen peroxide and glucose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |